DekaBank Deutsche Girozentrale Boosts Stock Holdings in Amdocs Limited (NASDAQ:DOX)

DekaBank Deutsche Girozentrale boosted its holdings in shares of Amdocs Limited (NASDAQ:DOXFree Report) by 4.9% during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 107,432 shares of the technology company’s stock after purchasing an additional 5,000 shares during the quarter. DekaBank Deutsche Girozentrale owned about 0.09% of Amdocs worth $9,192,000 as of its most recent SEC filing.

Several other large investors have also recently modified their holdings of DOX. Vanguard Group Inc. raised its stake in Amdocs by 1.4% in the 4th quarter. Vanguard Group Inc. now owns 1,457,368 shares of the technology company’s stock worth $128,088,000 after acquiring an additional 20,283 shares during the last quarter. Norden Group LLC acquired a new position in shares of Amdocs in the 1st quarter valued at $219,000. First Trust Direct Indexing L.P. boosted its holdings in Amdocs by 12.8% during the first quarter. First Trust Direct Indexing L.P. now owns 2,751 shares of the technology company’s stock worth $249,000 after buying an additional 312 shares in the last quarter. Tempus Wealth Planning LLC grew its position in Amdocs by 9.1% during the first quarter. Tempus Wealth Planning LLC now owns 3,977 shares of the technology company’s stock valued at $359,000 after buying an additional 333 shares during the period. Finally, New Century Financial Group LLC increased its holdings in Amdocs by 10.8% in the first quarter. New Century Financial Group LLC now owns 3,905 shares of the technology company’s stock valued at $353,000 after buying an additional 381 shares in the last quarter. Institutional investors own 92.02% of the company’s stock.

Analyst Ratings Changes

A number of research firms have recently commented on DOX. StockNews.com upgraded Amdocs from a “buy” rating to a “strong-buy” rating in a research report on Friday, October 25th. Stifel Nicolaus assumed coverage on Amdocs in a research note on Wednesday, October 2nd. They set a “buy” rating and a $100.00 target price for the company. One analyst has rated the stock with a hold rating, four have given a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat, the company has a consensus rating of “Buy” and a consensus target price of $102.00.

Check Out Our Latest Research Report on DOX

Amdocs Stock Performance

NASDAQ DOX opened at $88.09 on Thursday. The company has a debt-to-equity ratio of 0.21, a current ratio of 1.24 and a quick ratio of 1.24. Amdocs Limited has a 1-year low of $74.41 and a 1-year high of $94.04. The company has a market cap of $10.35 billion, a PE ratio of 19.80, a price-to-earnings-growth ratio of 1.42 and a beta of 0.74. The stock’s 50 day simple moving average is $87.30 and its 200-day simple moving average is $83.62.

Amdocs (NASDAQ:DOXGet Free Report) last announced its earnings results on Wednesday, August 7th. The technology company reported $1.62 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.60 by $0.02. The company had revenue of $1.25 billion for the quarter, compared to analysts’ expectations of $1.25 billion. Amdocs had a net margin of 10.21% and a return on equity of 17.89%. The firm’s quarterly revenue was up 1.1% on a year-over-year basis. During the same quarter in the previous year, the company posted $1.41 EPS. As a group, equities research analysts anticipate that Amdocs Limited will post 5.67 EPS for the current fiscal year.

Amdocs Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, October 25th. Shareholders of record on Monday, September 30th were paid a $0.479 dividend. This represents a $1.92 dividend on an annualized basis and a yield of 2.18%. The ex-dividend date of this dividend was Monday, September 30th. Amdocs’s dividend payout ratio (DPR) is 42.92%.

About Amdocs

(Free Report)

Amdocs Limited, through its subsidiaries, provides software and services worldwide. It designs, develops, operates, implements, supports, and markets open and modular cloud portfolio. The company provides CES23, a 5G and cloud-native microservices-based market-leading customer experience suite, that enables service providers to build, deliver, and monetize advanced services; Amdocs Subscription Marketplace, a software-as-a-service-based platform that includes an expansive network of pre-integrated digital services, such as media, gaming, eLearning, sports, and retail to security and business services; the monetization suite for charging, billing, policy, and revenue management; Intelligent networking suite with a set of modular, flexible, and open service lifecycle management capabilities for network automation journeys; amAIz, a telco GenAI framework; Amdocs Digital Brands Suite, a pre-integrated digital business suite; and Amdocs eSIM Cloud for service providers.

See Also

Want to see what other hedge funds are holding DOX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Amdocs Limited (NASDAQ:DOXFree Report).

Institutional Ownership by Quarter for Amdocs (NASDAQ:DOX)

Receive News & Ratings for Amdocs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amdocs and related companies with MarketBeat.com's FREE daily email newsletter.